Industry reports
Editor highlights

Generic Drug Industry in Russian Federation: Market Research Reports, Statistics and Analysis

» View Public Reports

14 reports

Investor presentation: Generic Drug in India and Russian Federation for Year 2012

  • Company report
  • March 2012
  • 29 pages

... Emerging market territories pharmaceutical services & active ingredients Fy12 revenue mix 25% of total Amongst the leaders in supply of generic apis globally Customers include generic manufactus ...

Company Report: Generic Drug in India, Russian Federation and The United States for Year 2012

  • Company report
  • March 2012
  • 6 pages
  • by Corporation

... In emerging markets. Lack of new launches and price erosion in us base business. Margin contraction due to higher sg&a & r&d costs. R&d spend to be +7% aided by development of biosimilars/niche products ...

Company Report: Generic Drug in Europe for Year 2012

  • Company report
  • March 2012
  • 2 pages

... Lorista (cardiovascular), nolpaza (gastro), prenessa (cardiovascular) and lanzul (gastro). In addition to generic drugs, krka also manages divisions of spa resorts, vet products and otc drug products ...

Company Report: Generic Drug in The United States, India and Russian Federation for Year 2012

  • Company report
  • March 2012
  • 7 pages
  • by Corporation

... While complex generics will be instrumental in us growth (1-3 launches per quarter). (3) R&d spends to remain higher (but in single digit) due to increased investments in biosimilars, complex ...

Company Report: Generic Drug in Russian Federation and India for Year 2012

  • Company report
  • March 2012
  • 7 pages

... Mg, isotretinoin, zoledronic acid (5mg/100ml), zoledronic acid (4mg/5ml) etc during previous quarters post sep 2012 and 4 new products which were launched during the quarter - azacitidine ...

Company Report: Generic Drug in Europe for Year 2012

  • Company report
  • March 2012
  • 2 pages

... Cardiovascular), zyllt (cardiovascular), lorista (cardiovascular), nolpaza (gastro), prenessa (cardiovascular) and lanzul (gastro). In addition to generic drugs, krka also manages divisions of spa resorts, vet ...

Company Report: Generic Drug in India, The United States and Russian Federation for Year 2011

  • Company report
  • March 2011
  • 11 pages

... Registering 31.8% Yoy growth, which was higher than our estimate of `2,272cr. The global generics market registered growth of 29.9% Yoy, led by growth across the u.S. And russian markets ...

Company Report: Generic Drug in Russian Federation for Year 2011

  • Company report
  • March 2011
  • 3 pages

... Highlights- revenues from global generics segment is at rs 191mn in q1fy13which is a yoy growth of 32% which is mainly driven by markets of north america, russia &emerging markets. Global generics ...

Company Report: Generic Drug in Russian Federation and India for Year 2011

  • Company report
  • March 2011
  • 3 pages

... To surprisingly more than expected price erosion in the few products (especially multiple player product launches) and as well increased competition in us generic market. Eventually, gross profit grew by 28 ...

Search in Generic Drug Industry

» Purchase Premium Reports (From $ 305 - $ 15 200)

11 reports
Russia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Russia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2013
  • by Business Monitor International

BMI View: Russia continues to offer both outsized risks and outsized opportunities for foreign drugmakers, according to BMI. Positive trends in recent years include increasing state coverage of medicines ...

Russia Pharmaceuticals And Healthcare Industry Update Q ...

July 2013 $ 1 300

Pharma Wholesale And Distribution Market: World Outlook ...

June 2013 $ 2 621

The Pharmaceutical Market: Russia, Business Monitor Int ...

January 2013 $ 1 337

Emerging Pharmaceutical Markets Globally

November 2011 $ 1 400

Actavis Generics Company Intelligence Report

January 2011 $ 341

Egis Generics Company Intelligence Report

January 2011 $ 341

Generic Drug In Australia: Brand Erosion Post-patent Ex ...

December 2010 $ 15 200

Intellectual Property Protection And Regulatory Regimes ...

December 2010 $ 3 835

Russia Pharmaceutical Industry Overview - - Pharma Indu ...

November 2010 $ 7 600

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.